Epitope Mapping of an Anti-EpCAM Monoclonal Antibody (EpMab-37) Using the Alanine Scanning Method
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 2023
DOI: 10.1089/mab.2022.0031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2023. Verfasst von Guanjie Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Alanine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
The epithelial cell adhesion molecule (EpCAM) is a type I transmembrane glycoprotein, and plays critical roles in cell adhesion, proliferation, and tumorigenesis. EpCAM has been considered as a promising target for tumor diagnosis and therapy. Anti-EpCAM monoclonal antibodies (mAbs) have been developed for EpCAM-overexpressed tumors, and several clinical trials have demonstrated promising outcomes. We previously established an anti-EpCAM mAb, EpMab-37 (mouse IgG 1 , kappa), using the Cell-Based Immunization and Screening method. EpMab-37 was revealed to recognize the conformational epitope of EpCAM. In this study, we determined the critical epitope of EpMab-37 by flow cytometry using the 1 × alanine scanning (1 × Ala-scan) and the 2 × alanine scanning (2 × Ala-scan) method. We first performed flow cytometry by 1 × Ala-scan using one alanine (or glycine)-substituted EpCAM mutants, which were expressed on Chinese hamster ovary-K1 cells, and found that the EpMab-37 did not recognize the R163A mutant of EpCAM. We next performed flow cytometry by 2 × Ala-scan using two alanine (or glycine) residues-substituted EpCAM mutants, and confirmed that EpMab-37 did not recognize R163A-including mutants of EpCAM. The results indicated that the critical binding epitope of EpMab-37 includes Arg163 of EpCAM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan.
ORCID-Profile: Takeo Yoshikawa, Yukinari Kato
Zitieren
APA
Li, G., Suzuki, H., Tanaka, T., Asano, T., Yoshikawa, T., Kaneko, M. K., & Kato, Y. (2023). Epitope Mapping of an Anti-EpCAM Monoclonal Antibody (EpMab-37) Using the Alanine Scanning Method. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. https://doi.org/10.1089/mab.2022.0031
Vancouver
Li G, Suzuki H, Tanaka T, Asano T, Yoshikawa T, Kaneko MK, et al. Epitope Mapping of an Anti-EpCAM Monoclonal Antibody (EpMab-37) Using the Alanine Scanning Method. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2023. doi:10.1089/mab.2022.0031
BibTeX
@article{Li2023,
author = {Li, Guanjie and Suzuki, Hiroyuki and Tanaka, Tomohiro and Asano, Teizo and Yoshikawa, Takeo and Kaneko, Mika K and Kato, Yukinari},
title = {Epitope Mapping of an Anti-EpCAM Monoclonal Antibody (EpMab-37) Using the Alanine Scanning Method},
journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
year = {2023},
doi = {10.1089/mab.2022.0031}
}
EUVIMED